Open | $158.570 |
Close | $156.760 |
Volume / Avg. | 6.602M / 7.153M |
Day Range | 156.500 - 158.690 |
52 Wk Range | 144.950 - 175.970 |
Market Cap | $377.758B |
P/E Ratio | 30.419 |
Dividend Yield | 3.010% |
Exchange | NYSE |
RSI | 41 |
Short Interest | 0.46% |
Days to Cover | 1.32 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Johnson & Johnson (NYSE: JNJ) through any online brokerage.
Other companies in Johnson & Johnson’s space includes: Novo Nordisk (NYSE:NVO), Merck & Co (NYSE:MRK), CymaBay Therapeutics (NASDAQ:CBAY), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
The latest price target for Johnson & Johnson (NYSE: JNJ) was reported by Cantor Fitzgerald on Wednesday, March 13, 2024. The analyst firm set a price target for 215.00 expecting JNJ to rise to within 12 months (a possible 37.15% upside). 52 analyst firms have reported ratings in the last year.
The stock price for Johnson & Johnson (NYSE: JNJ) is $156.76 last updated March 18, 2024 at 7:55 PM EDT.
A quarterly cash dividend of $1.19 per share of Class A Common Stock. The quarterly cash dividend was payable on March 5, 2024 to stockholders of record on February 16, 2024.
Johnson & Johnson’s Q1 earnings are confirmed for Tuesday, April 16, 2024.
There is no upcoming split for Johnson & Johnson.
Johnson & Johnson is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.